Regarding your earlier question about the impact of the progressive licensing framework, one of the core messages we'd like to deliver is that we don't want to lump all products together in one framework. The progressive licensing framework, if you look at the life cycle that they've described, starts with pre-clinical trial, clinical trial, new drug submission, new chemical entity, and all that.
When it comes to self-care products, none of that applies. They've been on the market for 20, 50, sometimes 100 years. They've been through all of that. If a product has been switched from prescription to non-prescription status, they've already had 20 years of experience with all of that.
So to have the same kinds of requirements that are anticipated for new chemical entities apply to everything under part C of the regulations would be a tremendous cost barrier to things like anti-dandruff shampoos, sunscreens, and other things that you can use every day for yourself. So that's a big thing.
With respect to the authority to recall, yes, I believe they should have the authority to recall. Health Canada has the ability to cancel your licence to market, so it's a very sharp tool with a big consequence. They can't say they want you to recall a product and keep it off the market while its under study. All they can do is say your product can no longer be marketed.
So they can take a product off, but it may be killing a mouse with a shotgun.